Biotechnology Stocks Continues To Show Impressive Growth in 2012 – (ARNA, THLD, ONXX, STEM, ARRY)

The biotechnology industry, which features companies such as Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Threshold Pharmaceuticals, Inc. (NASDAQ:THLD), has been showing a strong rally in 2012 as both large and small firms have demonstrated impressive growth. The SPDR S&P Biotech (ETF) (NYSEARCA:XBI) and the First Trust NYSE Arca Biotchnlgy Indx Fd (NYSEARCA:FBT) so far this year are up about 38%, outperforming the broader market by a wide margin.


Despite having to talk a more tough regulation process, biotech stocks have sustained to show investors strong gains in 2012. IMAP released a Pharmaceuticals & Biotechnology report disclosing that a number of pharmaceutical firms have changed their drug portfolios towards specialties like oncology, immunology and inflammation, where the medical demand is far above the ground and prices are more simply accepted by the regulators.

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals Inc. shares surged after the news that Company has gotten approval from the U.S Food and Drug Administration (FDA) of its Kyprolis (carfilzomib) for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma. Shares of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) touched a new 52-week high after approval from FDA and mounted earlier on Friday.

ONXX reported the gain of +11.67% and closed at $76.38 and traded above average volume of shares that was 9.45 million shares. Its price to earnings ratio ended at 99.57 and ONXX has earnings per share of $0.77. It gained 5.15% return on assets and 9.58% return on equity.

StemCells, Inc. (NASDAQ:STEM)

StemCells, Inc. (NASDAQ:STEM) is also one of the hot stocks from the Biotechnology industry. Shares of STEM gained a surge of 10.71% following its declaration of positive results from its Alzheimer’s preclinical trials, which indicated memory restoration and improved synaptic function after relocating human neural stem cells into animal models.

In last trading session, its volume was 6.42 million shares, more than the average volume of 1.21 million and closed at $1.55. STEM touched the day high price of $1.68 and day low of $1.31 while stock was opened at $1.41.

Array Biopharma Inc (NASDAQ:ARRY)

Array BioPharma Inc. is a biopharmaceutical company. ARRY also ended up positively and gained +7.09% to close at $4.30. Its total volume during last trading session was 1.25 million shares.

Surge and above average volume of shares of ARRY was gained when ARRY announced that it had signed an agreement with Amgen in 2009 for the worldwide development of the small-molecule glucokinase activator (GKA) program and achieved a target of $8.5 million in its collaboration with Amgen.

Banco Santander, S.A. (NYSE:SAN) May Widen 52-Week Low As European Finance Ministers Approve Rescue Aid For Spain – (ONXX, SAPX, ASTX)

Shares of Banco Santander, S.A. (ADR) (NYSE:SAN) moved down 4.89 percent to $4.86 in pre-market session from a record low level it marked on Friday. Spanish stocks faced a fall today as market participants guessed that a banking sector rescue fund and an empowerment of the EU’s financial aid could not solve Spain’s underlying economic problems. With Spanish region of Valencia looking for a salvage package from the Central Government, investors considered that a sovereign bailout would be necessary for Spain.


Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals Inc. opened higher Friday in early trade. Shares surged higher in the early afternoon and ended on $76.38 by moving up +11.67% on above average volume of 9.24 million shares.

Onyx Pharmaceuticals broke out of a one-month range and hit a new high of $79.20 for the year after the company announced that the FDA approved accelerated endorsement of Kyprolis for Injection, a proteasome inhibitor, indicated for the treatment of patients with multiple myeloma.

[article_detail_ad_1]Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) has net profit margin of 15.28% and operating margin of 19.48%. It gained 5.15% return on assets and its return on equity was 9.58%.


Seven Arts Pictures plc (NASDAQ:SAPX)

Seven Arts Pictures Plc is engaged in the production and licensing of motion pictures in the United Kingdom and overseas.

Shares of Seven Arts Pictures plc reported a gain after the SAPX announcement and the US theatrical release of the Film “Drunkboat.” The film, released on Friday, July 13th, exclusively through AMC Movie Theatres all over major cities to include Chicago, Los Angeles, New York and Boston.

Seven Arts Pictures plc (NASDAQ:SAPX) surged 25.00% to close at $0.0500 with the total traded volume of 3.83 million shares. Stock’s 52 weeks high price was $5.75 and 52 weeks low was $0.02.  SAPX has earnings per share of $1.25 and its price to earnings ratio ended at 0.04.


Astex Pharmaceuticals, Inc. (NASDAQ:ASTX)

Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) reported a gain of +13.51% and closed at $2.52 with the total traded volume of 4.83 million shares in last trading session. Its fifty two week range was $1.51-$3.16. The total market capitalization remained $234.64 million.

ASTX is ahead of its 52 week low with 66.89% and its last month price volatility remained 2.89%. Its beta coefficient was 1.05 with a target price of $4.25. In its share capital ASTX has 99.11 million outstanding shares while 90.27 million shares have been floated in market. ASTX has insider ownership of 0.52% while its institutional ownership remained 41.40%. Company’s current year earnings per share reduced with 7.24% while the five year EPS growth rate was +11.93%.